Announced Tue, 19 May · 16:48 IST

Audited Financial Results for the year ended March 31, 2026

Revenue Growth 20pctPat NegativeEbitda Margin CompressionDebt Equity ThresholdResults View source PDF

BHAGCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹246.55
prior close
₹252.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.0-1.0+0.1-3.3+2.8-1.2-0.4+1.0-0.6-1.4+4.3+16.5+10.4
Up moveDown movePending
AI summary

Bhagiradha Chemicals reported standalone revenue of Rs 52,122.21 lakhs for FY26, up 19.4% from Rs 43,635.74 lakhs in FY25. However, standalone profit after tax declined 4.2% to Rs 2,623.66 lakhs (vs Rs 2,739.03 lakhs), primarily due to higher financial costs (up 73% to Rs 1,138.76 lakhs) and increased material costs. Consolidated revenue grew 21.7% to Rs 53,594.33 lakhs with PAT rising 31.1% to Rs 1,817.32 lakhs (vs Rs 1,385.73 lakhs), aided by lower tax expense (Rs 293.39 lakhs vs Rs 1,139.23 lakhs). The company has a wholly-owned subsidiary, Bheema Fine Chemicals Private Limited. Statutory auditors issued an unmodified (clean) opinion. The Board recommended a final dividend of Rs 0.15 per share (15%), unchanged from FY25, subject to shareholder approval at the AGM on July 31, 2026.

Likely market impact

The company showed revenue growth but declining standalone profitability due to higher debt costs and material expenses. The consolidated profit growth is aided by tax benefits. Investors should monitor the rising debt levels and margin compression.